| Date |
Title |
| 15 Oct. 2025 |
Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights |
| 15 Oct. 2025 |
Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot |
| 14 Oct. 2025 |
Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025 |
| 1 Oct. 2025 |
Illumina launches new business to accelerate technology and data-driven discovery |
| 23 Sep. 2025 |
Illumina advances personalized cancer care with new pharma development partnerships |
| 18 Sep. 2025 |
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine |
| 3 Sep. 2025 |
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development |
| 31 Jul. 2025 |
Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025 |
| 30 Jul. 2025 |
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling |
| 10 Jul. 2025 |
Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025 |
| 10 Jul. 2025 |
Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year |
| 23 Jun. 2025 |
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy |
| 10 Jun. 2025 |
lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics |
| 29 May 2025 |
Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis |
| 28 May 2025 |
Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies |
| 26 May 2025 |
Illumina Comprehensive Genomic Profiling Test for Cancer Receives Regulatory Approval in Japan |
| 14 May 2025 |
Illumina To Webcast Upcoming Investor Conference |
| 13 May 2025 |
Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications |
| 8 May 2025 |
Illumina Reports Financial Results for First Quarter of Fiscal Year 2025 |
| 1 May 2025 |
Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development |
| 15 Apr. 2025 |
Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation |
| 10 Apr. 2025 |
Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025 |
| 25 Mar. 2025 |
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors |
| 19 Mar. 2025 |
Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery |
| 10 Mar. 2025 |
Illumina addresses recent developments in China |
| 6 Mar. 2025 |
Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year |
| 24 Feb. 2025 |
Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology |
| 21 Feb. 2025 |
Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions |
| 19 Feb. 2025 |
Illumina unveils first-of-its-kind spatial transcriptomics technology |
| 18 Feb. 2025 |
Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference |
| 6 Feb. 2025 |
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2024 |
| 14 Jan. 2025 |
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2024 and Provides Preliminary Outlook for Fiscal Year 2025 |
| 13 Jan. 2025 |
Illumina and NVIDIA collaborate to decode biology and propel precision health |
| 13 Jan. 2025 |
Illumina launches pilot proteomics program with UK Biobank and biopharma collaborators to analyze 50,000 samples |
| 9 Jan. 2025 |
Illumina to Announce Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6, 2025 |
| 7 Jan. 2025 |
Illumina advances NovaSeq X Series, delivering single-flow-cell system, software upgrade, and new kits to enable multiomic applications |